Cargando…

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis

AIMS: The study aimed to investigate the prevalence, phenotypic characteristics, and predictors of atrial fibrillation (AF) in patients presenting with cardiac amyloidosis (CA) of light‐chain (AL) or transthyretin (ATTR) type. METHODS AND RESULTS: Clinical, biochemical, and echocardiographic data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papathanasiou, Maria, Jakstaite, Aiste‐Monika, Oubari, Sara, Siebermair, Johannes, Wakili, Reza, Hoffmann, Julia, Carpinteiro, Alexander, Hagenacker, Tim, Thimm, Andreas, Rischpler, Christoph, Kessler, Lukas, Rassaf, Tienush, Luedike, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065861/ https://www.ncbi.nlm.nih.gov/pubmed/35178887 http://dx.doi.org/10.1002/ehf2.13851

Ejemplares similares

Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review
por: Papathanasiou, Maria, et al.
Publicado: (2020)

A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report
por: Thimm, Andreas, et al.
Publicado: (2022)

Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis
por: Thimm, Andreas, et al.
Publicado: (2023)

Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist
por: Papathanasiou, Maria, et al.
Publicado: (2020)

(18)F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Corneal confocal microscopy to detect early immune‐mediated small nerve fibre loss in AL amyloidosis
por: Thimm, Andreas, et al.
Publicado: (2022)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

Case report: incessant ventricular fibrillation in a conscious left ventricular assist device patient
por: Jakstaite, Aiste Monika, et al.
Publicado: (2021)

Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
por: Thimm, Andreas, et al.
Publicado: (2019)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Erectile dysfunction and quality of life in patients under left ventricular assist device support − an unspoken issue
por: Jakstaite, Aiste Monika, et al.
Publicado: (2023)

Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure
por: Papathanasiou, Maria, et al.
Publicado: (2023)

Cardiac fibroblast activation detected by (68)Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis
por: Siebermair, Johannes, et al.
Publicado: (2022)

Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
por: Jakstaite, Aiste‐Monika, et al.
Publicado: (2021)

Visualization of thermal damage using (68) Ga-FAPI-PET/CT after pulmonary vein isolation
por: Kupusovic, Jana, et al.
Publicado: (2021)

Central retinal artery occlusion as a first sign of atrial fibrillation: A 3‐year retrospective single‐center analysis
por: Vonderlin, Nadine, et al.
Publicado: (2021)

Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator
por: Kaya, Elif, et al.
Publicado: (2019)

Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
por: Kupusovic, Jana, et al.
Publicado: (2023)

Impact of diabetes as a risk factor in patients undergoing subcutaneous implantable cardioverter defibrillator implantation: A single-centre study
por: Kaya, Elif, et al.
Publicado: (2020)

Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19
por: Wesemann, Ulrich, et al.
Publicado: (2021)

Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutter
por: Vonderlin, Nadine, et al.
Publicado: (2023)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019)

Resternotomy does not adversely affect outcome after left ventricular assist device implantation
por: Papathanasiou, Maria, et al.
Publicado: (2017)

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)
por: Luedike, Peter, et al.
Publicado: (2018)

Structural components for the development of a heart failure network
por: Luedike, Peter, et al.
Publicado: (2022)

Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy
por: Alyaydin, Emyal, et al.
Publicado: (2023)

Subcutaneous ICD: Current standards and future perspective
por: Kaya, Elif, et al.
Publicado: (2019)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients
por: Wange, Niklas, et al.
Publicado: (2018)

Increased Dead Space Ventilation as a Contributing Factor to Persistent Exercise Limitation in Patients with a Left Ventricular Assist Device
por: Wernhart, Simon, et al.
Publicado: (2023)

Burden of hereditary transthyretin amyloidosis on quality of life
por: Yarlas, Aaron, et al.
Publicado: (2019)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
por: Ticau, Simina, et al.
Publicado: (2021)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gf5dkhda3r826pg8l4lsa9nkjv